ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 109 filers reported holding ANIKA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,255 | +103.9% | 336,058 | +184.5% | 0.03% | +100.0% |
| Q2 2023 | $3,067 | -38.3% | 118,143 | -31.8% | 0.01% | -40.9% |
| Q1 2023 | $4,970 | +7.5% | 173,146 | +10.8% | 0.02% | -4.3% |
| Q4 2022 | $4,624 | -99.9% | 156,267 | -2.7% | 0.02% | +9.5% |
| Q3 2022 | $3,821,000 | +257.1% | 160,604 | +235.2% | 0.02% | +320.0% |
| Q2 2022 | $1,070,000 | +3.2% | 47,912 | +15.8% | 0.01% | +25.0% |
| Q1 2022 | $1,037,000 | -19.9% | 41,386 | +14.5% | 0.00% | -20.0% |
| Q4 2021 | $1,294,000 | +10.2% | 36,132 | +30.7% | 0.01% | +25.0% |
| Q3 2021 | $1,174,000 | +137.2% | 27,649 | +141.6% | 0.00% | +100.0% |
| Q2 2021 | $495,000 | +450.0% | 11,446 | +418.9% | 0.00% | – |
| Q1 2021 | $90,000 | -74.5% | 2,206 | -71.7% | 0.00% | -100.0% |
| Q4 2020 | $353,000 | -87.3% | 7,804 | -90.1% | 0.00% | -91.7% |
| Q3 2020 | $2,776,000 | -75.0% | 78,435 | -73.3% | 0.01% | -75.0% |
| Q2 2020 | $11,086,000 | +2.6% | 293,894 | +49.3% | 0.05% | +4.3% |
| Q3 2019 | $10,804,000 | +1153.4% | 196,854 | +590.3% | 0.05% | +1050.0% |
| Q1 2019 | $862,000 | -60.1% | 28,517 | -35.3% | 0.00% | -60.0% |
| Q4 2016 | $2,159,000 | -53.1% | 44,086 | -54.1% | 0.01% | -56.5% |
| Q3 2016 | $4,600,000 | -40.3% | 96,118 | -33.1% | 0.02% | -41.0% |
| Q2 2016 | $7,710,000 | -0.8% | 143,720 | -17.3% | 0.04% | 0.0% |
| Q1 2016 | $7,771,000 | +37.5% | 173,771 | +17.4% | 0.04% | +30.0% |
| Q4 2015 | $5,650,000 | +29.3% | 148,044 | +7.9% | 0.03% | +25.0% |
| Q3 2015 | $4,369,000 | -36.8% | 137,260 | -34.4% | 0.02% | -29.4% |
| Q2 2015 | $6,916,000 | -5.7% | 209,396 | +17.5% | 0.03% | 0.0% |
| Q1 2015 | $7,335,000 | +169.8% | 178,162 | +167.0% | 0.03% | +183.3% |
| Q4 2014 | $2,719,000 | +414.0% | 66,733 | +362.1% | 0.01% | +300.0% |
| Q3 2014 | $529,000 | -72.7% | 14,441 | -65.5% | 0.00% | -66.7% |
| Q2 2014 | $1,937,000 | -74.9% | 41,807 | -77.7% | 0.01% | -77.5% |
| Q1 2014 | $7,719,000 | -1.2% | 187,795 | -8.3% | 0.04% | -9.1% |
| Q4 2013 | $7,815,000 | +185.6% | 204,778 | +78.8% | 0.04% | +144.4% |
| Q3 2013 | $2,736,000 | – | 114,550 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |